Teo AKK, Wagers AJ, Kulkarni RN. New opportunities: harnessing induced pluripotency for discovery in diabetes and metabolism. Cell metabolism. 2013;18(6):775–791.
Publications
2013
2012
Galkina E V, Butcher M, Keller SR, Goff M, Bruce A, Pei H, Sarembock IJ, Sanders JM, Nagelin MH, Srinivasan S, et al. Accelerated atherosclerosis in Apoe-/- mice heterozygous for the insulin receptor and the insulin receptor substrate-1. Arteriosclerosis, thrombosis, and vascular biology. 2012;32(2):247–256.
Lee EK, Kim W, Tominaga K, Martindale JL, Yang X, Subaran SS, Carlson OD, Mercken EM, Kulkarni RN, Akamatsu W, et al. RNA-binding protein HuD controls insulin translation. Molecular cell. 2012;45(6):826–835.
Halperin F, Lopez X, Manning R, Kahn R, Kulkarni RN, Goldfine AB. Insulin augmentation of glucose-stimulated insulin secretion is impaired in insulin-resistant humans. Diabetes. 2012;61(2):301–309.
Morioka T, Dishinger JF, Reid KR, Liew CW, Zhang T, Inaba M, Kennedy RT, Kulkarni RN. Enhanced GLP-1-and sulfonylurea-induced insulin secretion in islets lacking leptin signaling. Molecular Endocrinology. 2012;26(6):967–976.
Kim W, Lao Q, Shin Y-K, Carlson OD, Lee EK, Gorospe M, Kulkarni RN, Egan JM. Cannabinoids induce pancreatic beta-cell death by directly inhibiting insulin receptor activation. Sci. Signal. 2012;5(216):ra23–ra23.
Kebede M, Ferdaoussi M, Mancini A, Alquier T, Kulkarni RN, Walker MD, Poitout V. Glucose activates free fatty acid receptor 1 gene transcription via phosphatidylinositol-3-kinase-dependent O-GlcNAcylation of pancreas-duodenum homeobox-1. Proceedings of the National Academy of Sciences. 2012;109(7):2376–2381.
Welters HJ, Ouaamari AE, Kawamori D, Meyer J, Hu J, Smith DM, Kulkarni RN. Rosiglitazone promotes PPAR$\gamma$-dependent and-independent alterations in gene expression in mouse islets. Endocrinology. 2012;153(10):4593–4599.
Kulkarni RN. Identifying biomarkers of subclinical diabetes. Diabetes. 2012;61(8):1925–1926.
Kulkarni RN, Mizrachi E-B, Ocana AG, Stewart AF. Human beta cell proliferation and intracellular signaling: driving in the dark without a roadmap. Diabetes. 2012;61(9):2205–2213.